"The impact of quadrivalent human papillomavirus (HPV; Types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years"

"Background. Human papillomavirus (HPV)-6/11/16/18 vaccine reduces the risk of HPV-6/11/16/18-related cervical intraepithelial neoplasia (CIN) 1-3 or adenocarcinoma in situ (AIS). Here, its impact on CIN1-3/AIS associated with nonvaccine oncogenic HPV types was evaluated. Methods. We enrolled 1...

Descripción completa

Detalles Bibliográficos
Autores Principales: Brown, Darron R, Kjaer, Susanne K, Sigurdsson, Kristján, Iversen, Ole-Erik, Hernandez-Avila, Mauricio, Wheeler, Cosette M, Perez, Gonzalo, Koutsky, Laura A, Tay, Eng Hseon, Garcia, Patricía, Ault, Kevin A, Garland, Suzanne M, Leodolter, Sepp, Olsson, Sven-Eric, Tang, Grace W K, Ferris, Daron G, Paavonen, Jorma, Steben, Marc, Bosch, F Xavier, Dillner, Joakim, Joura, Elmar A, Kurman, Robert J, Majewski, Slawomir, Muñoz, Nubia, Myers, Evan R, Villa, Luisa L, Taddeo, Frank J, Roberts, Christine, Tadesse, Amha, Bryan, Janine, Lupinacci, Lisa C, Giacoletti, Katherine E D, Sings, Heather L, James, Margaret, Hesley, Teresa M, Barr, Eliav
Formato: Artículo (Article)
Lenguaje:Inglés (English)
Publicado: 2009
Materias:
Acceso en línea:https://repository.urosario.edu.co/handle/10336/22373
https://doi.org/10.1086/597307